当前位置: X-MOL 学术Lancet HIV › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Status of the HIV epidemic in key populations in the Middle East and north Africa: knowns and unknowns
The Lancet HIV ( IF 12.8 ) Pub Date : 2022-06-28 , DOI: 10.1016/s2352-3018(22)00093-5
Ghina R Mumtaz 1 , Hiam Chemaitelly 2 , Sawsan AlMukdad 3 , Aisha Osman 3 , Sasha Fahme 4 , Nesrine A Rizk 5 , Shereen El Feki 6 , Laith J Abu-Raddad 7
Affiliation  

The Middle East and north Africa is one of only two world regions where HIV incidence is on the rise, with most infections occurring among key populations: people who inject drugs, men who have sex with men, and female sex workers. In this Review, we show a trend of increasing HIV prevalence among the three key populations in the Middle East and north Africa. Although the epidemic continues at a low level in some countries or localities within a country, there is evidence for concentrated epidemics, with sustained transmission at considerable HIV prevalence among people who inject drugs and men who have sex with men in over half of countries in the region with data, and among female sex workers in several countries. Most epidemics emerged around 2003 or thereafter. The status of the epidemic among key populations remains unknown in several countries due to persistent data gaps. The HIV response in Middle East and north Africa remains far below global targets for prevention, testing, and treatment. It is hindered by underfunding, poor surveillance, and stigma, all of which are compounded by widespread conflict and humanitarian crises, and most recently, the advent of COVID-19. Investment is needed to put the region on track towards the target of eliminating HIV/AIDS as a global health threat by 2030. Reaching this target will not be possible without tailoring the response to the needs of key populations, while addressing, to the extent possible, the complex structural and operational barriers to success.



中文翻译:

中东和北非重点人群的艾滋病流行状况:已知与未知

中东和北非是世界上仅有的两个艾滋病毒发病率上升的地区之一,大多数感染发生在重点人群中:注射吸毒者、男男性行为者和女性性工作者。在本次审查中,我们展示了中东和北非三个重点人群中艾滋病毒感染率上升的趋势。尽管该流行病在一个国家内的一些国家或地区继续处于低水平,但有证据表明流行病集中,在半数以上国家的注射吸毒者和男男性行为者中持续传播的艾滋病毒感染率相当高。有数据的地区,以及几个国家的女性性工作者。大多数流行病是在 2003 年左右或之后出现的。由于持续存在数据缺口,一些国家的重点人群中的流行状况仍然未知。中东和北非的艾滋病毒应对工作仍远低于全球预防、检测和治疗目标。它受到资金不足、监督不力和污名化的阻碍,所有这些都因广泛的冲突和人道主义危机以及最近 COVID-19 的出现而加剧。需要进行投资,以使该地区走上到 2030 年消除作为全球健康威胁的艾滋病毒/艾滋病这一目标的轨道。如果不根据关键人群的需求量身定制应对措施,同时尽可能解决问题,就不可能实现这一目标,成功的复杂结构和运营障碍。中东和北非的艾滋病毒应对工作仍远低于全球预防、检测和治疗目标。它受到资金不足、监督不力和污名化的阻碍,所有这些都因广泛的冲突和人道主义危机以及最近 COVID-19 的出现而加剧。需要进行投资,以使该地区走上到 2030 年消除作为全球健康威胁的艾滋病毒/艾滋病这一目标的轨道。如果不根据关键人群的需求量身定制应对措施,同时尽可能解决问题,就不可能实现这一目标,成功的复杂结构和运营障碍。中东和北非的艾滋病毒应对工作仍远低于全球预防、检测和治疗目标。它受到资金不足、监督不力和污名化的阻碍,所有这些都因广泛的冲突和人道主义危机以及最近 COVID-19 的出现而加剧。需要进行投资,以使该地区走上到 2030 年消除作为全球健康威胁的艾滋病毒/艾滋病这一目标的轨道。如果不根据关键人群的需求量身定制应对措施,同时尽可能解决问题,就不可能实现这一目标,成功的复杂结构和运营障碍。COVID-19 的出现。需要进行投资,以使该地区走上到 2030 年消除作为全球健康威胁的艾滋病毒/艾滋病这一目标的轨道。如果不根据关键人群的需求量身定制应对措施,同时尽可能解决问题,就不可能实现这一目标,成功的复杂结构和运营障碍。COVID-19 的出现。需要进行投资,以使该地区走上到 2030 年消除作为全球健康威胁的艾滋病毒/艾滋病这一目标的轨道。如果不根据关键人群的需求量身定制应对措施,同时尽可能解决问题,就不可能实现这一目标,成功的复杂结构和运营障碍。

更新日期:2022-06-29
down
wechat
bug